Jul 2026· Ecotoxicology and Environmental Safety· Vol 322, pp.
120484
· 1 citation· 42 references
Medicine
TL;DR
A pivotal role for m7G modification in environmental neurotoxicant-induced neurodegeneration is established and cobalt-related RNA regulatory paradigm is revealed that expands the understanding of heavy metal-driven epitranscriptomic dysregulation, and hence offering novel therapeutic targets.
Abstract
Excessive cobalt exposure adversely affects the nervous system, yet the underlying neurotoxic mechanisms remain largely elusive. In the present study, using human neuroblastoma H4 cells exposed to cobalt chloride (CoCl₂) as an in vitro model, we demonstrate for the first time that CoCl₂ induces widespread alterations in m7G modification in genes associated with neurodegenerative disease. MeRIP-sequencing (MeRIP-seq) analysis revealed significant remodeling of m7G modification features, including sequence motifs, genomic distribution, and peak densities following CoCl₂ exposure. Differentially methylated genes were enriched in pathways governing nervous system function, neurotransmitter transport, neuronal projection guidance, axonogenesis, and axonal guidance. Integration of MeRIP-seq and RNA-seq data further demonstrated that CoCl₂ concurrently induced differential m7G methylation and expression of genes implicated in central nervous system function and neurodegenerative disease pathways. Mechanistically, CoCl₂ suppressed m7G modification levels by downregulating the methyltransferase complex components methyltransferase-like 1 (METTL1) and WD repeat domain 4 (WDR4). More importantly, METTL1 overexpression attenuated CoCl₂-induced downregulation of neurodegenerative disease-associated genes runt-related transcription factor 2 (RUNX2), repulsive guidance molecule A (RGMA), and unc-5 netrin receptor C (UNC5C) by modulating mRNA decay. Moreover, MeRIP-qPCR further confirmed that cobalt exposure significantly reduced m7G modification on these transcripts, and this reduction was restored by METTL1 overexpression, thereby supporting a regulatory role of m7G modification in target mRNA expression. These findings establish a pivotal role for m7G modification in environmental neurotoxicant-induced neurodegeneration and reveal cobalt-related RNA regulatory paradigm that expands our understanding of heavy metal-driven epitranscriptomic dysregulation, and hence offering novel therapeutic targets.
Advances provide the first chemical foothold for therapeutic modulation of m7G pathways and underscore METTL1 as a promising yet complex target requiring careful biological stratification.
Emanuele Fabbrizi, Gebremedhin S. Hailu, Andrea Mancini et al.· Journal of Medicinal Chemist...· 0 citations
It is revealed that m7G methyltransferase METTL1 plays an oncogenic role in MNNG-induced gastric carcinogenesis and SLC2A3 is a key downstream target of METTL1, which is associated with clinical progression in GC patients.
Jia-Xian Li, Jiabei Jian, Wen-Zheng Yuan et al.· Current Medicinal Chemistry· 0 citations
This study reveals for the first time the complete molecular mechanism by which ZCCHC4-mediated UHRF1 m6A methylation promotes OS progression through epigenetic suppression of CDO1 transcription and inhibition of ferroptosis.
Kai Song, Ju Liu, Bo-Wen Han et al.· Bone· 0 citations
Overexpression of CHCHD2 in METTL5-KO NPCs rescued proliferation and partially rescued oxidative metabolism in NPCs and ventricle formation in organoids, highlighting a previously uncharacterized connection between CHCHD2, oxidative metabolism, and METTL5-mediated regulation of human neurogenesis.
Elena M. Turkalj, Gugene Kang, I. Liu et al.· Stem Cell Reports· 0 citations
This review systematically synthesizes current knowledge regarding the multifaceted roles of YTHDC2 in disease progression, prognosis, and therapy, offering a comprehensive framework to guide future investigations.
Yan-Ying Hu, Qi Zhou, Ning Xu et al.· Cells· 0 citations
It is revealed that m6A-regulated MYC signaling orchestrates DNA repair and metabolic remodeling to promote CRC chemoresistance and highlights the METTL3–YTHDF1–MYC axis as a promising target for predictive precision therapy and combined therapeutic interventions.
Kai Wang, Song Geng, Zhengping Xiao et al.· Molecular and Cellular Bioch...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.